By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Hutchison China MediTech (Chi-Med) 

21st Floor, Hutchison House
10 Harcourt Road
Hong Kong      China
Phone: 852-2121-8200 Fax: 852-2121-8281


SEARCH JOBS


Industry
Pharmaceutical






Company News
Hutchison China MediTech (Chi-Med) To Participate In Two Healthcare Investor Conferences In May 5/3/2016 11:13:30 AM
Hutchison China MediTech (Chi-Med) Announces Exercise Of Overallotment Option 4/13/2016 10:43:35 AM
Hutchison China MediTech (Chi-Med) Initiates First-In-Human Clinical Trial Of Novel PI3K Inhibitor HMPL-689 4/12/2016 9:45:18 AM
Hutchison China MediTech (Chi-Med) Announces Closing Of U.S. Public Offering Of Adss Raising Approximately US$101 Million On The Nasdaq Stock Market 3/22/2016 8:38:05 AM
Hutchison China MediTech (Chi-Med) Initiates Sulfatinib Phase III Registration Study In Pancreatic Neuroendocrine Tumor Patients 3/21/2016 10:45:53 AM
Hutchison China MediTech (Chi-Med) Completes US Offering At Lowered Price Of $13.50/ADS 3/18/2016 8:56:08 AM
Week In Review: Hutchison China MediTech (Chi-Med) To Raise $100 Million In US Offering Next Week 3/14/2016 9:23:23 AM
Hutchison China MediTech (Chi-Med) To Complete $100 Million U.S. IPO Next Week 3/8/2016 9:30:18 AM
Hutchison China MediTech (Chi-Med) Announces Launch Of Potential U.S. Public Offering Of ADSs 3/7/2016 12:41:04 PM
Hutchison China MediTech (Chi-Med) Initiates Sulfatinib Phase II Clinical Trial In Thyroid Cancer 3/2/2016 11:04:17 AM
1234
//-->